- Home
- TD vs JNJ Comparison
TD vs JNJ Comparison
Compare TD & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TD | JNJ |
|---|---|---|
| Founded | 1855 | 1886 |
| Country | Canada | United States |
| Employees | 102218 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.3B | 589.2B |
| IPO Year | N/A | 2003 |
Fundamental Metrics
Financial Performance| Metric | TD | JNJ |
|---|---|---|
| Price | $94.34 | $243.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 18 |
| Target Price | $120.00 | ★ $229.89 |
| AVG Volume (30 Days) | 1.6M | ★ 7.0M |
| Earning Date | 01-01-0001 | 04-21-2026 |
| Dividend Yield | ★ 3.17% | 2.14% |
| EPS Growth | N/A | ★ 90.50 |
| EPS | N/A | ★ 11.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.63 |
| Revenue Next Year | $4.22 | $7.23 |
| P/E Ratio | ★ $11.65 | $22.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $54.87 | $141.50 |
| 52 Week High | $99.84 | $251.71 |
Technical Indicators
Market Signals| Indicator | TD | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 43.42 | 58.25 |
| Support Level | $93.09 | $201.37 |
| Resistance Level | $96.41 | $251.71 |
| Average True Range (ATR) | 1.88 | 4.12 |
| MACD | -0.40 | -1.31 |
| Stochastic Oscillator | 6.98 | 51.44 |
Price Performance
Historical ComparisonAbout TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.